1887

Abstract

Sulphoevernan is a sulphated α-1 → 3, 1 → 4 polyglucan ( 20000) with a helical structure. This compound effectively inhibits both human immunodeficiency virus type 1 (HIV-1) and type 2 infection of cells at concentrations around 0.5 µg/ml. Moreover, the compound completely inhibits HIV-1-induced syncytium formation at a concentration of 1 µg/ml. Competition experiments with S-labelled sulphoevernan revealed that the mannose-specific lectin from prevented binding of sulphoevernan to HIV-1, whereas the antibody OKT4A did not reduce the amount of sulphoevernan bound to MT-2 cells. These data indicate that the non-cytotoxic polymer sulphoevernan binds to the virus rather than to the host cell. studies, using Rauscher leukaemia virus in NMRI mice, revealed that, at a daily dose of 20 mg/kg, the animals were protected against virus-induced increases in spleen weight. From these and data we conclude that sulphoevernan has potential in the treatment of acquired immunodeficiency syndrome.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-71-9-1957
1990-09-01
2019-11-23
Loading full text...

Full text loading...

http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-71-9-1957
Loading

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error